Author Correction: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/ NF-κB inactivation

Xuefen Xu; Xiaobo Zhang; Yi Zhang; Lin Yang; Yicheng Liu; Shaoliang Huang; Lu Lu; Lingyi Kong; Zhiyu Li; Qinglong Guo; Li Zhao

doi:10.1038/s41598-021-91964-z

Scientific Reports (Jun 2021)

Author Correction: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/ NF-κB inactivation

Xuefen Xu,
Xiaobo Zhang,
Yi Zhang,
Lin Yang,
Yicheng Liu,
Shaoliang Huang,
Lu Lu,
Lingyi Kong,
Zhiyu Li,
Qinglong Guo,
Li Zhao

Affiliations

Xuefen Xu: State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University
Xiaobo Zhang: State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University
Yi Zhang: State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University
Lin Yang: State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University
Yicheng Liu: State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University
Shaoliang Huang: State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University
Lu Lu: State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University
Lingyi Kong: State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, China Pharmaceutical University
Zhiyu Li: State Key Laboratory of Natural Medicines, Department of Natural Medicinal Chemistry, China Pharmaceutical University
Qinglong Guo: State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University
Li Zhao: State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University

DOI: https://doi.org/10.1038/s41598-021-91964-z
Journal volume & issue: Vol. 11, no. 1
pp. 1 – 4

Abstract

Read online

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Published in Scientific Reports

ISSN: 2045-2322 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Medicine; Science
Website: https://www.nature.com/srep/

About the journal